Carsten Corvey

Carsten Corvey has a significant amount of work experience in the pharmaceutical industry. Carsten began their career at Sanofi in 2005, where they worked as a Labhead for four years before being promoted to Group Leader Assays And Analytics. In 2013, they became a Global Project Leader at the company. Carsten then transitioned to Merck Group in 2017, where they served as a Global Project Leader in Early Stage Project Management for three years. In 2021, they joined MorphoSys as Vice President - Head Biologics Development & Analytics, and later became Vice President - Head of Research. From 2023 onwards, Carsten will assume the role of Global Program Head Tulmimetostat (CPI-0209) and Global Head Translational Sciences at MorphoSys.

Carsten Corvey pursued their education in the field of Pharmaceutical Chemistry/Microbiology at Goethe University Frankfurt. from 1995 to 2001. During this time, they successfully completed their Ph.D., earning the degree of Doktor.